Women who give birth to boys more likely to suffer from depression

Washington D.C. [USA], Nov 7 (ANI): According to a recent study, women who give birth to males are 71-79 per cent more likely to develop postnatal depression (PND).

Furthermore, women who went into labour under complications were 174 per cent more likely to experience PND compared to those women who had no complications, according to a study published in the Journal of Social Science and Medicine.

Researchers at the University of Kent studied PND and found that the odds of developing this condition increased by 79 per cent when mothers had baby boys compared to baby girls.

As a result of their findings, researchers Dr. Sarah Johns and Dr. Sarah Myers concluded that recognising that both male infants and birth complications are PND risk factors should help health professionals in identifying and supporting women who may be more likely to develop this condition.

Their research also showed that while women with a tendency towards symptoms of depression, anxiety, and stress were always at increased risk of PND, they had reduced odds of developing PND after experiencing birth complications. This is likely because these women may receive greater post-birth support because their mental health concerns were previously recognised. This finding suggests intervention to support women can be effective in preventing PND from developing.

Dr. Johns said, “PND is a condition that is avoidable, and it has been shown that giving women at risk extra help and support can make it less likely to develop. The finding that having a baby boy or a difficult birth increases a woman’s risk gives health practitioners two new and easy ways to identify women who would particularly benefit from additional support in the first few weeks and months.”

Both the gestation of male fetuses and the experience of birth complications have documented associations with increased inflammation, yet, until this study, their relationships with PND were unclear.

Many known risk factors for depressive symptoms are associated with activation of inflammatory pathways, opening up the potential for identifying new risk factors based on their inflammation causing effects – an idea supported by this study. (ANI)

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

    Medical Negligence and Quackery Rampant: 9-Year-Old Dies from Wrong Injection, Pregnant Woman Succumbs to Quack Treatment, Raids Uncover Illegal Practices Across MP, Haryana, UP & Chhattisgarh

    Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

    Drug Diversion Epidemic Sweeps India: Absence of Track-and-Trace System, overly Codeine Allotments, and Regulatory Apathy Fuel Misuse of Narcotic Syrups and Tablets

    Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

    Multi-State Supply Chain of Fake RituxiRel and Alburel Injections Exposed Amid Health Risks

    TN, Karnataka, Rajasthan declare highest number of NSQs in January

    TN, Karnataka, Rajasthan declare highest number of NSQs in January

    Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

    Centre reorganises CDSCO Zone Baddi amid Drug Quality Concerns

    CDSCO modifies norms for testing permissions to speed up drug approvals

    CDSCO modifies norms for testing permissions to speed up drug approvals